Advanced Search

Table of Contents

November 01, 2005; Volume 3, Issue 4

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Michael A. Hillman

Impact of Age, CYP2C9 Genotype and Concomitant Medication on the Rate of Rise for Prothrombin Time During the First 30 Days of Warfarin Therapy
Russell A. Wilke, Richard L. Berg, Humberto J. Vidaillet, Michael D. Caldwell, James K. Burmester and Michael A. Hillman
- Clinical Medicine & Research November 2005, 3 (4) 207-213;
- DOI: https://doi.org/10.3121/cmr.3.4.207

Michael D. Caldwell

Impact of Age, CYP2C9 Genotype and Concomitant Medication on the Rate of Rise for Prothrombin Time During the First 30 Days of Warfarin Therapy
Russell A. Wilke, Richard L. Berg, Humberto J. Vidaillet, Michael D. Caldwell, James K. Burmester and Michael A. Hillman
- Clinical Medicine & Research November 2005, 3 (4) 207-213;
- DOI: https://doi.org/10.3121/cmr.3.4.207

In this Issue

Sign up for alerts